Johannan F. Brandse
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Anti-drug antibodies against anti-TNF in patients with inflammatory bowel disease: an evaluation of possible strategies.
Journal: Scandinavian journal of gastroenterology
Published: November 14, 2023
Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: October 23, 2021
Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial.
Journal: Scandinavian journal of gastroenterology
Published: December 08, 2020
Successful Treatment of Oral Crohn's Disease by Ustekinumab.
Journal: Inflammatory bowel diseases
Published: January 08, 2020
Pharmacokinetics of golimumab in moderate to severe ulcerative colitis: the GO-KINETIC study.
Journal: Scandinavian journal of gastroenterology
Published: May 28, 2019
Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: April 17, 2019
Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel Disease.
Journal: Journal of Crohn's & colitis
Published: April 03, 2018
Benzimidazoles Promote Anti-TNF Mediated Induction of Regulatory Macrophages and Enhance Therapeutic Efficacy in a Murine Model.
Journal: Journal of Crohn's & colitis
Published: May 09, 2017
A Real-life Population Pharmacokinetic Study Reveals Factors Associated with Clearance and Immunogenicity of Infliximab in Inflammatory Bowel Disease.
Journal: Inflammatory bowel diseases
Published: February 15, 2017
Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies.
Journal: Annals of the rheumatic diseases
Published: December 27, 2016
Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.
Journal: Inflammatory bowel diseases
Published: March 16, 2016
Last Updated: 09/26/2026